The ACCC has granted interim authorisation to enable eRx Script Exchange Pty Ltd (eRx) to continue to give effect to a revenue sharing arrangement with IP MDS Pty Ltd (formerly MediSecure Pty Ltd (MDS). The revenue sharing arrangement facilitates the interoperability between the parties’ electronic pharmaceutical prescription exchange systems.
eRx has an existing authorisation in place for the revenue sharing agreement, which expires on 30 June 2020. Interim authorisation will allow the arrangements to continue while the ACCC considers eRx’s application for reauthorisation.
Interim authorisation commences immediately and protects the revenue sharing arrangement for which authorisation is sought from legal action under the relevant provisions of the Competition and Consumer Act 2010 while the ACCC considers and evaluates the merits of the application. The ACCC may review the interim authorisation at any time and its interim authorisation decision should not be taken to be indicative of whether or not final authorisation will be granted.
Further information about the application for authorisation and the ACCC’s interim authorisation decision is available on the authorisation public register at: eRx Script Exchange Pty Ltd.